EXEL
USDExelixis Inc. Common Stock
السعر في الوقت الحقيقي
مخطط الأسعار
المقاييس الرئيسية
مقاييس السوق
الافتتاح
$37.810
الأعلى
$38.900
الأدنى
$37.582
الحجم
2.81M
أساسيات الشركة
القيمة السوقية
10.2B
الصناعة
التكنولوجيا الحيوية
البلد
United States
إحصاءات التداول
متوسط الحجم
2.62M
البورصة
NMS
العملة
USD
نطاق 52 أسبوعاً
أخبار ذات صلة
Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update
- Total Revenues of $597.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $542.9 million - - GAAP Diluted EPS of $0.69, Non-GAAP Diluted EPS of $0.78 - - Announced Additional Stock Repurchase Program for
Guggenheim Downgrades Exelixis to Neutral
Guggenheim analyst Michael W. Schmidt downgrades Exelixis from Buy to Neutral.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or the "Company") (NASDAQ: EXEL). Such investors are...
Exelixis to Release Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT – Exelixis, Inc. (NASDAQ:EXEL) announced today that its third quarter 2025 financial results will be released on Tuesday, November 4, 2025 after
Morgan Stanley Maintains Overweight on Exelixis, Lowers Price Target to $44
Morgan Stanley analyst Sean Laaman maintains Exelixis with a Overweight and lowers the price target from $50 to $44.
RBC Capital Reiterates Sector Perform on Exelixis, Maintains $45 Price Target
RBC Capital analyst Leonid Timashev reiterates Exelixis with a Sector Perform and maintains $45 price target.
Wells Fargo Maintains Equal-Weight on Exelixis, Lowers Price Target to $30
Wells Fargo analyst Derek Archila maintains Exelixis with a Equal-Weight and lowers the price target from $36 to $30.
أسهم ذات صلة
ابق على اطلاع
تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.